Equities
Health CareMedical Equipment and Services
  • Price (SEK)32.86
  • Today's Change0.02 / 0.06%
  • Shares traded248.46k
  • 1 Year change-12.75%
  • Beta0.5131
Data delayed at least 15 minutes, as of Nov 22 2024 10:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Arjo AB (publ) grew revenues 10.03% from 9.98bn to 10.98bn while net income improved 7.14% from 448.00m to 480.00m.
Gross margin43.64%
Net profit margin4.56%
Operating margin8.31%
Return on assets3.26%
Return on equity6.55%
Return on investment4.62%
More ▼

Cash flow in SEKView more

In 2023, Arjo AB (publ) did not generate a significant amount of cash. However, the company earned 2.06bn from its operations for a Cash Flow Margin of 18.77%. In addition the company used 637.00m on investing activities and also paid 1.43bn in financing cash flows.
Cash flow per share5.50
Price/Cash flow per share5.58
Book value per share28.87
Tangible book value per share1.34
More ▼

Balance sheet in SEKView more

Arjo AB (publ) has a Debt to Total Capital ratio of 40.73%, a higher figure than the previous year's 40.13%.
Current ratio0.9129
Quick ratio0.626
Total debt/total equity0.6873
Total debt/total capital0.4073
More ▼

Growth rates in SEK

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 5.88% and 6.90%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
Div yield(5 year avg)1.48%
Div growth rate (5 year)10.35%
Payout ratio (TTM)47.97%
EPS growth(5 years)10.15
EPS (TTM) vs
TTM 1 year ago
30.03
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.